Summary
Small study reports the results of a single center randomized, double-blind, placebo-controlled, parallel group trial of memantine in adults with multiple sclerosis. Mult Scler. 2009 Dec 22
Details
Small study reports the results of a single center randomized, double-blind, placebo-controlled, parallel group trial of memantine in adults with multiple sclerosis and spasticity conducted over 12 weeks. Eligible MS patients were required to have an Ashworth spasticity rating of 2 or higher in at least one lower extremity muscle group.
Twenty-one subjects were randomized to receive either placebo(ten) or memantine (11) 10 mg twice a day. The primary outcome
measure of efficacy was a change in Ashworth Spasticity Scale
Score. Although well tolerated, memantine treatment did not
demonstrate efficacy in treatment of spasticity in this 12-week
small exploratory study.
National Research and Programs